Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2020 | 04-2019 | 04-2018 | 04-2017 | 04-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,827 | -4,067 | -6,829 | -4,444 | -6,064 |
| Accounts payable and accrued liabilities | 64 | -231 | -13 | 30 | -161 |
| Other Working Capital | 267 | 167 | -86 | -21 | -874 |
| Other Operating Activity | 1,157 | 1,253 | 1,848 | 1,096 | 2,752 |
| Operating Cash Flow | $-2,338 | $-2,878 | $-5,079 | $-3,340 | $-4,346 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 75 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,663 | 2,343 | 2,681 | 4,882 | 3,568 |
| Other Financing Activity | -12 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $2,726 | $2,343 | $2,681 | $4,882 | $3,568 |
| Exchange Rate Effect | -8 | -9 | -6 | 1 | -1 |
| Beginning Cash Position | 515 | 1,060 | 3,464 | 1,921 | 2,700 |
| End Cash Position | 895 | 515 | 1,060 | 3,464 | 1,921 |
| Net Cash Flow | $380 | $-545 | $-2,404 | $1,543 | $-779 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,338 | -2,878 | -5,079 | -3,340 | -4,346 |
| Free Cash Flow | -2,338 | -2,878 | -5,079 | -3,340 | -4,346 |